Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001062993-12-001712
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-14 14:11:07
Reporting Period:
2012-05-10
Filing Date:
2012-05-14
Accepted Time:
2012-05-14 13:11:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369868 China Biologic Products Inc. CBPO Biological Products, (No Disgnostic Substances) (2836) 752308816
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331795 David Gao 18Th Floor, Jialong International
Building, 19 Chaoyang Park Road
Beijing F4 100125
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-11 4,290 $9.50 4,290 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2012-05-10 300,000 $0.00 300,000 $9.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
320,000 2022-05-11 No 4 A Direct
Footnotes
  1. Granted pursuant to a stock option agreement dated May 11, 2012 between the Company and Mr. Gao (the "Stock Option Agreement"). Pursuant to the Stock Option Agreement, the stock options will vest in twelve equal portions on a quarterly basis over a 3-year period, with the first portion vesting on August 11, 2012, provided that Mr. Gao is employed by the Company on each vesting date.
  2. As of May 14, 2012, Mr. Gao is the holder of stock options to purchase an aggregate of 320,000 shares of common stock of the Issuer, among which the stock options to purchase 20,000 shares were granted pursuant to a stock option agreement dated as of October 6, 2011 between the Company and Mr. Gao.